Malaka-Zafiriu K, Papadopoulos F, Avgoustidou-Savopoulou P, Papachristos F
Clin Ther. 1984;6(2):178-84.
The therapeutic efficacy of 25 mg/kg of cefadroxil administered once daily was compared with that of 50 mg/kg/day of ampicillin administered in four equal doses in the treatment of acute uncomplicated urinary tract infections (UTIs) in children. Nineteen girls and seven boys (mean age, 5.5 years) received cefadroxil, and 18 girls and eight boys (mean age, 5.9 years) received ampicillin. The clinical and bacteriological characteristics, as well as the demographic characteristics, of both populations were well matched. Patients with structural anomalies or with a history of hypersensitivity to cephalosporins or penicillins or abnormal hepatorenal function were excluded from the trial. Only patients with at least two consecutive positive cultures of a single pathogen, obtained in clean-catch midstream urine samples (greater than or equal to 10(5) colony-forming units per ml urine) and susceptible to the respective antibiotic, were admitted to the study. Urine cultures were repeated during the ten days of treatment and ten days after the completion of treatment. All patients in the cefadroxil group were evaluated as clinically and bacteriologically cured. Three (12%) of the patients in the ampicillin group had positive cultures in the immediate post-treatment period. The differences in the cure rates of the two groups were not statistically significant. No adverse effects of either antibiotic were observed.
将每日一次给予25mg/kg头孢羟氨苄的治疗效果与每日50mg/kg氨苄西林分四次等量给予的治疗效果进行比较,以治疗儿童急性单纯性尿路感染(UTIs)。19名女孩和7名男孩(平均年龄5.5岁)接受头孢羟氨苄治疗,18名女孩和8名男孩(平均年龄5.9岁)接受氨苄西林治疗。两组人群的临床、细菌学特征以及人口统计学特征匹配良好。有结构异常或对头孢菌素或青霉素过敏史或肝肾功能异常的患者被排除在试验之外。只有在清洁中段尿样本(每毫升尿液中菌落形成单位大于或等于10(5))中获得至少两次单一病原体连续阳性培养且对相应抗生素敏感的患者才被纳入研究。在治疗的十天内以及治疗结束后的十天内重复进行尿培养。头孢羟氨苄组的所有患者在临床和细菌学上均被评估为治愈。氨苄西林组中有3名(12%)患者在治疗后即刻培养结果为阳性。两组治愈率的差异无统计学意义。未观察到两种抗生素的不良反应。